Updated:
Berry Family Office
David and Eric Berry established the office in 2022. David built Seres Therapeutics and Indigo Agriculture. Eric sold TripleLift for $1.4 billion.
Berry Family Office
David and Eric Berry established the office in 2022. David built Seres Therapeutics and Indigo Agriculture. Eric sold TripleLift for $1.4 billion. The firm invests only family assets. The office targets three areas. Human health receives capital for technologies that alter disease trajectories. Artificial intelligence receives commitments to companies that create durable value. Market inefficiencies receive allocations through custom instruments that exploit pricing gaps. All activity stays inside North America and uses direct co-investments or SPVs rather than fund commitments. No public data exist on assets under management, headcount, or additional offices. The website lists no portfolio holdings or co-investors. No operational events from the last 24 months appear in available records.
General information
Firm type
Single Family Office
Year founded
2022
Location
Region
North America
Country
United States
City
Boston
Corporate office
Newton, MA, United States
Principals
David Berry
Founder
Eric Berry
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Berry Family Office?
David and Eric Berry make decisions as the founding principals. No external CIO or investment committee is disclosed.
Does Berry Family Office participate in fund commitments or only direct deals?
The firm uses direct co-investments and SPVs. No fund commitments are mentioned on its site.
What investment stages does Berry Family Office typically target?
The office targets startups. No stage restrictions beyond that appear in public materials.
Where does the underlying wealth come from?
Wealth originates from David Berry's biotech companies Seres Therapeutics and Indigo Agriculture plus Eric Berry's sale of TripleLift.
Which sectors does Berry Family Office explicitly avoid?
No avoidance list is published. Public materials name only human health, AI, and market inefficiencies as active areas.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: